Evidence map›Paper›PMID 42295559›Full record

Trial reportThe international journal of cardiovascular imaging2026

A simplified geometric CMR method for reproducible quantification of left ventricular thrombus volume : Left Ventricular thrombus: a standardized measurement method.

Antonin Fuzeau, Denis Angoulvant, Julien Pucheux, Nicolas Cazeneuve, Claire Bouleti, Loïc Biere, Didier Bresson, Ahmad Hayek, Charles De Bourguignon, Cyrille Bergerot and 7 more

Abstract readClinical Trial, Phase IIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Antonin FuzeauCardiology, Centre Hospitalier Universitaire Trousseau, Tours, France. a.fuzeau@chu-tours.fr.
Denis AngoulvantCardiology, Centre Hospitalier Universitaire Trousseau, Tours, France.
Julien PucheuxRadiology, Centre Hospitalier Universitaire Trousseau, Tours, France.
Nicolas CazeneuveRadiology, Centre Hospitalier Universitaire Trousseau, Tours, France.
Claire BouletiClinical Investigation Center (CIC) INSERM 1402, Poitiers University Hospital, Poitiers, France.
Loïc BiereDepartment of Cardiology and SFR ICAT, University Hospital of Angers, Angers, F-49000, France.
Didier BressonUniversity Hospital of Mulhouse, Hôpital Emile Muller, Mulhouse, France.
Ahmad HayekCardiology, Clinical Investigation Center Inserm 1407, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, Auvergne-Rhône-Alpes, France.
Charles De BourguignonCardiology, Clinical Investigation Center Inserm 1407, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, Auvergne-Rhône-Alpes, France.
Cyrille BergerotCardiology, Clinical Investigation Center Inserm 1407, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, Auvergne-Rhône-Alpes, France.
Naoual El JonhyCardiology, Clinical Investigation Center Inserm 1407, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, Auvergne-Rhône-Alpes, France.
Simon LeboubeCardiology, Clinical Investigation Center Inserm 1407, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, Auvergne-Rhône-Alpes, France.
Marine TortigueCardiopaediatrics, Hospices Civils de Lyon, Auvergne-Rhône-Alpes, France.
Benoit LattucaACTION Study Group, Cardiology Department, Nîmes University Hospital, Montpellier University, Nîmes, France.
François RoubilleACTION Study Group, Cardiology Department, Montpellier University Hospital, Montpellier University, Montpellier, France.
Nathan MewtonCardiology, Clinical Investigation Center Inserm 1407, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, Auvergne-Rhône-Alpes, France.
Pierre CroisilleUniv Lyon, CREATIS, UJM-Saint-Etienne, INSA, CNRS UMR 5520, INSERM U1294, Saint-Etienne F-42023, Saint-Etienne, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Left ventricular thrombus (LVT) is a frequent complication after myocardial infarction and is associated with increased risk of systemic embolism and adverse cardiovascular outcomes. However, the relationship between thrombus characteristics and its clinical evolution remains poorly understood, partly due to the lack of standardized and reproducible measurement methods. This study evaluated the feasibility and reproducibility of a simplified geometric CMR approach for standardized LVT volume assessment. This post-hoc analysis included patients from the COVERT-MI trial who underwent cardiac magnetic resonance (CMR) imaging 5 days after reperfusion for ST-segment elevation myocardial infarction. LVT volume was estimated using a simplified geometric method based on three orthogonal measurements (ABC/2 formula). Thrombus morphology, surface area, and insertion circumference were also assessed. Inter- and intra-reader reproducibility were evaluated using Bland-Altman analysis and Cohen's kappa coefficients. Associations with thrombus persistence at 3 months and clinical outcomes at 1 year were explored as secondary analyses. Among 161 patients who underwent baseline CMR, 25 (15.5%) had LVT. The mean estimated thrombus volume was 1.03 ± 1.09 cm³. At 3 months, thrombus regression occurred in 80% of patients. The ABC/2 method showed high reproducibility. Inter-observer reproducibility demonstrated a bias of 0.07 cm³, whereas intra-observer reproducibility showed a bias of 0.03 cm³. Inter-observer correlation was high (r = 0.86, SEE = 0.51 cm³), while intra-observer correlation was excellent (r = 0.99, SEE = 0.15 cm³). Accounting for thrombus shape had minimal impact on volume estimation (mean difference 0.035 cm³). No thrombus characteristic was significantly associated with thrombus persistence, and no cardioembolic events occurred during the 1-year follow-up. A simplified geometric CMR approach based on the ABC/2 formula provides a feasible and highly reproducible framework for estimating LVT volume. Further studies in larger cohorts are needed to determine the clinical and prognostic relevance of quantitative thrombus assessment.

Indexed as

Heart VentriclesMagnetic Resonance Imaging, CineST Elevation Myocardial InfarctionThrombosisAgedFeasibility StudiesFemaleHumansImage Interpretation, Computer-AssistedMaleMiddle AgedObserver VariationPredictive Value of TestsReproducibility of ResultsTime FactorsTreatment OutcomeCardiac magnetic resonanceCardiovascular imagingLeft ventricular thrombusSTEMI

Identifiers

PMID42295559
PMCPMC13645997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.